CM
AXSM icon

Caption Management’s Axsome Therapeutics AXSM Stock Holding History

Caption Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7M Sell
60,000
-73,900
-55% -$16M 0.07% 303
2026
Q1 		$22.6M Buy
133,900
+8,900
+7% +$1.54M 0.13% 162
2025
Q4 		$22.8M Buy
125,000
+100,000
+400% +$14M 0.16% 151
2025
Q3 		$3.04M Hold
25,000
– – 0.02% 665
2025
Q2 		$2.61M Sell
25,000
-27,200
-52% -$2.88M 0.03% 636
2025
Q1 		$6.09M Sell
52,200
-76,700
-60% -$8.74M 0.06% 326
2024
Q4 		$10.9M Buy
128,900
+93,900
+268% +$8.64M 0.1% 173
2024
Q3 		$3.15M Buy
+35,000
New +$3.06M 0.05% 430
2024
Q2 		– Sell
-38,500
Closed -$3.07M – 1150
2024
Q1 		$3.07M Buy
+38,500
New +$3.23M 0.05% 424
2023
Q4 		– Sell
-10,100
Closed -$706K – 1331
2023
Q3 		$706K Sell
10,100
-17,400
-63% -$1.3M 0.01% 864
2023
Q2 		$1.98M Sell
27,500
-2,500
-8% -$184K 0.04% 496
2023
Q1 		$1.85M Sell
30,000
-5,000
-14% -$328K 0.04% 459
2022
Q4 		$2.7M Buy
+35,000
New +$2.09M 0.04% 478
2022
Q3 		– Sell
-195,000
Closed -$7.47M – 1488
2022
Q2 		$7.47M Buy
195,000
+157,500
+420% +$4.98M 0.1% 255
2022
Q1 		$1.55M Sell
37,500
-2,500
-6% -$77.5K 0.02% 839
2021
Q4 		$1.51M Buy
+40,000
New +$1.47M 0.02% 889
2020
Q2 		– Sell
-17,500
Closed -$1.03M – 926
2020
Q1 		$1.03M Sell
17,500
-37,500
-68% -$3.06M 0.06% 396
2019
Q4 		$5.68M Sell
55,000
-225,400
-80% -$9.1M 0.19% 143
2019
Q3 		$5.67M Buy
280,400
+215,400
+331% +$5.53M 0.3% 94
2019
Q2 		$1.67M Sell
65,000
-22,500
-26% -$451K 0.08% 283
2019
Q1 		$1.25M Buy
+87,500
New +$812K 0.07% 303

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Caption Management's AXSM Position: Q1 2025 in Review

Caption Management sold out of Axsome Therapeutics (AXSM) in Q1 2025, closing a stake of 115,686 shares — an estimated $13.2M sold.

Caption Management first reported a position in AXSM in Q1 2019 and held it in 10 quarters. The position peaked at $9.79M in Q4 2024. 353 funds tracked by Wall St. Rank hold AXSM as of Q1 2025.

  • Caption Management reported no remaining Axsome Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Caption Management sold 115,686 Axsome Therapeutics shares in Q1 2025, an estimated $13.2M.
  • Caption Management first reported a position in Axsome Therapeutics in Q1 2019 and held it in 10 quarters.
  • Caption Management's Axsome Therapeutics position peaked at $9.79M in Q4 2024.
  • 353 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2025.

Based on Caption Management's 13F filing for Q1 2025, filed 15 May 2025.